Not Signed In -
Glaucoma |
|
|
Clinical Trial: Comparison of the Effects of Two Glaucoma Drugs Over 24 Hours
This study is not yet open for patient recruitment.
|
Purpose
This study is comparing 2 medications for glaucoma and how effective they are at controlling glaucoma over the course of an entire day.
| Condition | Treatment or Intervention | Phase |
|---|---|---|
| Glaucoma Ocular Hypertension | | Phase II Phase III |
MedlinePlus related topics: Eye Diseases; Glaucoma
Study Type: Interventional
Study Design: Treatment, Randomized, Double-Blind, Active Control, Crossover Assignment, Efficacy Study
Eligibility
Ages Eligible for Study: 18 Years and above, Genders Eligible for Study: Both
Criteria
Inclusion Criteria:
- Patients with glaucoma or ocular hypertension
Exclusion Criteria:
- Other eye conditions
- Poor vision
- Recent eye surgery
- Use of contact lenses
- Nursing or pregnant women
- Use of some other selected medications
- Drug or alcohol abuse
- Asthma
- Slow heart beat
- Allergy or previous reaction to study drugs
Location Information
Toll Free Number 1-888-577-8839
More Information
Study ID Numbers: 2005_021
Record last reviewed: April 2005
Last Updated: April 12, 2005
Record first received: April 12, 2005
ClinicalTrials.gov Identifier: NCT00108017
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2005-04-14
Record last reviewed: April 2005
Last Updated: April 12, 2005
Record first received: April 12, 2005
ClinicalTrials.gov Identifier: NCT00108017
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2005-04-14
Source: ClinicalTrials.gov
Cache Date: April 14, 2005
email this page
print this page
bookmark this page
feedback on this page
